IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Go back to IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

IGM Biosciences Inc. (IGMS) Misses Q4 EPS by 6c

March 26, 2020 4:15 PM EDT

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43).

2019 was a transformational year for IGM. The many highlights of the year included our successful... More